Acadia Pharma (ACAD) on Watch Amid rumors of Allergan (AGN) Interest

September 28, 2016 1:04 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.


Acadia Pharma (Nasdaq: ACAD) was in focus Wednesday on reports it could attract interest from Allergan (NYSE: AGN). DealReporter was the source of today's speculation.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment